|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 3/06 | (2006.01) | ||
| C07K 16/40 | (2013.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3689913 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19210918.9 |
| Date of filing the European patent application | 2014-10-10 | |
| (97) | Date of publication of the European application | 2020-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361890154 P | 2013-10-11 | US | |
| 201461923103 P | 2014-01-02 | US | |
| 201461955514 P | 2014-03-19 | US | |
| 201462004620 P | 2014-05-29 | US | |
| 201462025104 P | 2014-07-16 | US | |
| 14306221 | 2014-07-31 | EP | |
| 201462054571 P | 2014-09-24 | US | |
| 14306584 | 2014-10-09 | EP |
| (72) |
BACCARA-DINET, Marie , FR
BESSAC, Laurence , FR
CHAUDHARI, Umesh , US
HANOTIN, Corinne , FR
PORDY, Robert C. , US
SASIELA, William J. , US
SCHWEMMER GIPE, Daniel A. , US
|
| (73) |
Sanofi Biotechnology ,
54 rue La Boétie, 75008 Paris,
FR
Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591, US |
| (54) | USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA |
| USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA |